home / stock / medxf / medxf quote
Last: | $1.34 |
---|---|
Change Percent: | -3.08% |
Open: | $1.34 |
Close: | $1.34 |
High: | $1.34 |
Low: | $1.34 |
Volume: | 755 |
Last Trade Date Time: | 05/06/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$1.34 | $1.34 | $1.34 | $1.34 | $1.34 | 755 | 05-06-2024 |
$1.3 | $1.3028 | $1.3 | $1.3028 | $1.3 | 350 | 05-03-2024 |
$1.32 | $1.295 | $1.32 | $1.32 | $1.29 | 6,878 | 05-02-2024 |
$1.275 | $1.3 | $1.275 | $1.3 | $1.25 | 5,517 | 05-01-2024 |
$1.345 | $1.345 | $1.345 | $1.345 | $1.345 | 1,100 | 04-30-2024 |
$1.45 | $1.46 | $1.45 | $1.466 | $1.4425 | 28,425 | 04-29-2024 |
$1.385 | $1.3285 | $1.385 | $1.385 | $1.3285 | 3,360 | 04-26-2024 |
$1.35 | $1.3 | $1.35 | $1.38 | $1.2815 | 27,992 | 04-25-2024 |
$1.3 | $1.267 | $1.3 | $1.3032 | $1.255 | 19,880 | 04-24-2024 |
$1.215 | $1.215 | $1.215 | $1.215 | $1.215 | 3,300 | 04-23-2024 |
$1.17 | $1.17 | $1.17 | $1.17 | $1.17 | 300 | 04-22-2024 |
$1.2185 | $1.1628 | $1.2185 | $1.2428 | $1.14 | 40,000 | 04-19-2024 |
$1.1 | $1.09 | $1.1 | $1.11 | $1.08 | 29,200 | 04-18-2024 |
$1.11 | $1.11 | $1.11 | $1.1175 | $1.1072 | 11,700 | 04-17-2024 |
$1.1 | $1.12 | $1.1 | $1.1215 | $1.1 | 14,610 | 04-16-2024 |
$1.1415 | $1.14 | $1.1415 | $1.17 | $1.14 | 19,548 | 04-15-2024 |
$1.14 | $1.1301 | $1.14 | $1.18 | $1.1201 | 36,841 | 04-12-2024 |
$1.15 | $1.125 | $1.15 | $1.175 | $1.125 | 23,914 | 04-11-2024 |
$1.14 | $1.1199 | $1.14 | $1.165 | $1.1126 | 19,329 | 04-10-2024 |
$1.135 | $1.17 | $1.135 | $1.2 | $1.135 | 23,644 | 04-09-2024 |
News, Short Squeeze, Breakout and More Instantly...
Medexus Pharmaceuticals Inc Company Name:
MEDXF Stock Symbol:
OTCMKTS Market:
Toronto, Ontario and Chicago, Illinois--(Newsfile Corp. - May 1, 2024) - Following a trial in January 2023, Canada's Federal Court has issued a judgment declining to uphold the Canadian patent for Metoject®. Medexus Pharmaceuticals (TSX: MDP) (OTCQX: MEDXF) and medac, licensor of Medexus's c...
Toronto, Ontario and Chicago, Illinois--(Newsfile Corp. - April 2, 2024) - Medexus Pharmaceuticals (TSX: MDP) (OTCQX: MEDXF) is pleased to announce that company management will be participating in the 2024 Bloom Burton & Co. Healthcare Investor Conference from April 16 to 17, 2024. Event : ...
Expanded indication includes patients under 12 years of age, based on Phase 3/4 data demonstrating safety and efficacy in previously treated patients in this age group Toronto, Ontario and Chicago, Illinois--(Newsfile Corp. - March 26, 2024) - Medexus Pharmaceuticals (TSX: MDP) (OTCQX: MEDXF) to...